Arkolith/Insider Trading/APTO/Form 4

Bejar Rafael

InsiderAptose Biosciences Inc. (APTO) · full profile →Form 4 · filed Jul 1, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
1 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2026Disposed to issuer(D)244$1.72$4200

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2026Disposed to issuer(D)35K—$00
Jun 30, 2026Disposed to issuer(D)200K—$00
Jun 30, 2026Disposed to issuer(D)400K—$00
Jun 30, 2026Disposed to issuer(D)343K—$00
Jun 30, 2026Disposed to issuer(D)200K—$00
Jun 30, 2026Disposed to issuer(D)400K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000912282-26-000893) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML